✦ LIBER ✦

Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice

✍ Scribed by Burkhardt, Olaf; Derendorf, Hartmut; Welte, Tobias

Book ID: 118146628
Publisher: Informa plc
Year: 2007
Tongue: English
Weight: 452 KB
Volume: 8
Category: Article
ISSN: 1465-6566
DOI: 10.1517/14656566.8.2.237

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Patterns of lamotrigine use in daily cli

Patterns of lamotrigine use in daily clinical practice during the first 5 years after introduction in the Netherlands

✍ P. D. Knoester; S. V. Belitser; C. L. P. Deckers; A. Keyser; W. O. Renier; A. C. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB

Metastatic esophagogastric adenocarcinom

Metastatic esophagogastric adenocarcinoma: trends in first-line treatment and predictive factors for the implementation of HER2 testing in clinical practice during the first year after trastuzumab market approval

✍ Deniz Gencer, Salah-Eddin Al-Batran, Reyad Dada, Ali-Nuri Hünerlitürkoglu, Micha 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 452 KB

ANNOUNCEMENTS: 4th Annual Meeting of the

ANNOUNCEMENTS: 4th Annual Meeting of the Association for Ocular Pharmacology and Therapeutics (AOPT) The Marriott, Irvine, CA, USA 28–31 January 1999, Keystone Symposia Ocular Cell & Molecular Biology (OCMB) Announces Dean Bok, Ph.D. as the winner of the first OCMB Prize, Keystone OCMB Symposium, 1999 Keystone Colorado 5–10 February 1999, Call for Abstracts and Registration Organizers: Steven E. Wilson and Joe Hollyfield Registration and Abstract Forms available from: Keystone Symposia on Molecular and Cellular Biology Drawer 1630 Silverthorn, Colorado 80498 Telephone: 800-253-0685 Fax: 970-262-1525 E-mail: [email protected], XIV International Congress of Eye Research Santa Fe, New Mexico 15–20 October 2000, XV International Congress of Eye Research (2002) Proposals for the International Congress of Eye Research meeting to be held in the year 2002 are now being accepted by the ISER Council. The Jules François Prize of the Belgian Ophthalmological Societies 2000 The aim of the Jules François Prize is to encourage scientific research in ophthalmology. The prize of 10.000 U.S. Dollars will be awarded to a young scientist who has made an important contribution to ophthalmology. Eligibility: All topics in the field of fundamental and/or clinical research in ophthalmology will be considered. The application should be sent jointly with a curriculum vitae, the list of all publications and 3 copies of the candidates' 10 most relevant publications. The candidate should not be older than 40 years by 31 December 1999. Mailing Address: Jules François Foundation Secretary Prof. Dr. M. Hanssens Dienst Oogheelkunde De Pintelaan 185 B-9000 Gent, Belgium

📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 235 KB

MAGNA CARTAThe Great CharterPreamble

📂 Fiction 🌐 English ⚖ 11 KB 👁 18 views